Author, Year | 1.1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 | 1.8 | 1.9 | 1.10 | Overall assessment |
---|
Miller, 2012 [61] | Y | Y | Y | Y | Y | Y | CS | Tx blinded: 0 Tx not-blinded: 0 No tx: 12 | Y | N/A | + |
Sawyer, 1999 [32] | Y | Y | Y | Y | N | Y | CS | SMT: 0% (0/9) Placebo: 9% (1/11) | Y | N/A | + |
- Y yes, N no, N/A not applicable, CS can’t say; ++: high quality; +: acceptable quality; −: unacceptable quality/rejected
- Legend: RCTs
- 1.1 Research Question
- 1.2 Method of Randomization
- 1.3 Concealment
- 1.4 Blinding
- 1.5 Baseline Characteristics
- 1. 6 Contamination
- 1.7 Outcome Measurement
- 1.8 Lost to Follow-Up
- 1.9 Intention-to-Treat
- 1.10 Between Sites